This startup specializes in mental health treatments using Transcranial Magnetic Stimulation (TMS), Spravato, Ketamine Therapy, and psychiatric services for treatment-resistant conditions such as depression, anxiety, OCD, and PTSD. By providing these targeted therapies, the company aims to improve patient outcomes for individuals who have not responded to traditional treatment methods.
Funding
Funding not disclosed
Founders
Product
Problem
Many individuals with treatment-resistant mental health conditions, such as depression, anxiety, OCD, and PTSD, do not respond to traditional treatments like medication and therapy. This lack of effective treatment options can lead to prolonged suffering and reduced quality of life.
Solution
This startup offers specialized mental health treatments for individuals with treatment-resistant conditions. The company provides Transcranial Magnetic Stimulation (TMS), Spravato, and Ketamine Therapy, alongside general psychiatric services, to target the neurobiological mechanisms underlying these conditions. By utilizing these advanced therapies, the company aims to provide relief and improve outcomes for patients who have not found success with conventional approaches. The treatments are tailored to each individual's specific needs and condition, offering a personalized approach to mental healthcare.
Target Audience
The primary target audience includes individuals with treatment-resistant depression, anxiety, OCD, PTSD, and other mental health conditions who have not responded adequately to traditional treatments.
Features
- Transcranial Magnetic Stimulation (TMS) for non-invasive brain stimulation
- Spravato (esketamine) treatments for rapid relief of depressive symptoms
- Ketamine Therapy for treatment-resistant depression and other mental health disorders
- Comprehensive psychiatric evaluations and medication management
- Individualized treatment plans tailored to each patient's needs